Purpura - 88 Studies Found
| Completed |
: Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura : 2010-06-25 :
|
| Completed |
: Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura : Acquired Thrombotic Thrombocytopenic Purpura : 2015-09-14 :
|
| Completed |
: The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura (TTP) : 2009-07-09 : Drug: Rituximab Concentrate for solution for infusion, Intravenous use, 375mg/m2, Maximum 8 weekly infus |
| Terminated |
: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura (TTP) : 2006-12-13 :
|
| Completed |
: Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) : Hereditary Thrombotic Thrombocytopenic Purpura (TTP) : 2014-08-12 : Drug: Recombinant ADAMTS13 rADAMTS13 (a disintegrin and me |
| Completed |
: Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura : Thrombotic Thrombocytopenic Purpura : 2012-03-08 : Biological: rituximab rituximab intravenously 100 mg every week for four doses |
| Not yet recruiting |
: Octaplas Adult TTP Trial : Thrombotic Thrombocytopenic Purpura : 2013-09-02 :
|
| Terminated |
: Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura : 2008-11-26 :
|
| Enrolling by invitation |
: A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura :
: 2013-02-22 : Drug: N-Acetylcysteine IV administration of N-Acetylcysteine at 150mg/kg over 60 min first, then if well |
| Completed |
: ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders :
|